Cite

HARVARD Citation

    Matza, L. et al. (2020). Assessing patient PREFERence between the dulaglutide pen and the semaglutide pen: A crossover study (PREFER). Diabetes, obesity & metabolism. 22 (3), pp. 355-364. [Online]. 
  
Back to record